Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials.
Lists
Only you see this
Abstract
This study systematically reviewed and evaluated all relevant RCTs and found that adjunctive aripiprazole is effective and safe to use in the treatment of antipsychotic-induced HPL. However, the low quality of some of the studies, the incomplete methodological information provided for most of the studies, and the relatively short follow-up time of the studies raises question about the validity of the results. Further work that resolves these methodological and reporting issues is needed.
BibTeX
@inproceedings{meng2015using,
author = {Meiling Meng and Wei Li and Shaowei Zhang and Hongyan Wang and Jianhua Sheng and Jijun Wang and Chunbo Li},
title = {{Using aripiprazole to reduce antipsychotic-induced hyperprolactinemia: meta-analysis of currently available randomized controlled trials.}},
booktitle = {PubMed},
year = {2015},
doi = {10.11919/j.issn.1002-0829.215014},
}Loading related content...